Three times more likely to report moderate to severe pain
Among women facing mastectomy, a quiet deficiency in vitamin D appears to amplify the suffering that follows the surgeon's work — tripling the likelihood of significant postoperative pain and drawing patients deeper into reliance on opioid medications. A study of 184 women in Egypt has illuminated a connection long hinted at by vitamin D's known role in inflammation and immune regulation, suggesting that something as accessible as a supplement taken before surgery might ease a burden that has, until now, been accepted as inevitable. The finding invites medicine to look not only at what happens on the operating table, but at what a patient carries into it.
- Breast cancer patients with low vitamin D were three times more likely to wake from mastectomy in moderate to severe pain — a gap that widened with every hour of the first postoperative day.
- The deficient group consumed dramatically more tramadol, averaging 112 milligrams through self-administered doses, deepening their exposure to a drug that brings its own catalogue of harms.
- Nausea and vomiting clustered in the vitamin D deficient group, compounding a recovery already shadowed by pain and the psychological weight of cancer surgery.
- Researchers cannot yet explain the full mechanism — inflammatory pathways are suspected, but markers were not measured, and confounding factors like anxiety and prior treatment remain unaccounted for.
- A single-hospital observational study cannot prove causation, but it points urgently toward a controlled trial and raises the immediate question of whether preoperative supplementation should become standard screening practice.
A study published in Regional Anesthesia & Pain Medicine has found that breast cancer patients with vitamin D deficiency experience substantially more pain after mastectomy and turn to opioid medications far more often than those with adequate levels. Conducted at Fayoum University Hospital in Egypt between September 2024 and April 2025, the research followed 184 women — half deficient, half sufficient — who were otherwise similar in age and received identical surgical and pain management protocols.
The divergence appeared in the recovery room. Deficient patients were three times more likely to report moderate to severe pain in the first 24 hours, and consumed an average of 112 milligrams of tramadol compared to their counterparts. A modest difference in intraoperative fentanyl use was also observed. Nausea was more common in the deficient group, and vomiting occurred exclusively among them, though the numbers were too small to reach statistical significance.
Vitamin D's suspected role involves its anti-inflammatory properties and influence on immune function — both of which shape how the body registers and processes pain. Deficiency is already known to be disproportionately common among breast cancer patients, making the population studied particularly relevant.
The researchers are candid about the study's limits: it is observational, single-site, and did not measure inflammatory markers or account for psychological and clinical variables that shape pain perception. Cause and effect cannot be confirmed. Still, the team concluded that deficiency is meaningfully associated with worse postoperative pain and greater opioid reliance, and they recommend that patients with vitamin D levels below 30 nmol/L be considered for supplementation before surgery. A randomized controlled trial, they note, is the necessary next step to determine whether correcting the deficiency can genuinely reduce suffering — and the opioid burden that follows it.
A study of breast cancer patients undergoing mastectomy has found that those with low vitamin D levels experience significantly more pain after surgery and rely more heavily on opioid medications to manage it. The research, published in Regional Anesthesia & Pain Medicine, tracked 184 women at Fayoum University Hospital in Egypt between September 2024 and April 2025—half with vitamin D levels below 30 nmol/L and half with sufficient levels. Both groups were similar in age (averaging 42 to 44 years old) and received identical surgical protocols and pain management during their procedures.
The difference emerged in the hours after surgery. Patients with vitamin D deficiency were three times more likely to report moderate to severe pain during the first 24 hours following their operation. Importantly, no patient in either group experienced the most severe pain levels; the gap came down to a reduction in moderate pain among those with adequate vitamin D. The vitamin D deficient group also used substantially more tramadol—a strong opioid they could self-administer by pressing a button—consuming an average of 112 milligrams compared to their counterparts. During surgery itself, the deficient group received slightly more fentanyl, though researchers described this difference as modest.
The mechanism behind this connection remains incompletely understood, though emerging evidence suggests vitamin D plays a role in how the body processes pain. The vitamin appears to work through its anti-inflammatory properties and its effects on immune system function. Vitamin D deficiency is already known to be common among breast cancer patients, making the finding potentially significant for a vulnerable population.
The opioid medications used to manage postoperative pain carry their own burdens. Beyond their effectiveness, these drugs frequently cause nausea, vomiting, drowsiness, and confusion. They also carry risks of dependency and addiction. In this study, patients with vitamin D deficiency experienced more postoperative nausea, and vomiting occurred only in that group, though the difference was small enough that it did not reach statistical significance.
The researchers acknowledge their study's limitations. It was observational and conducted at a single hospital, so it cannot establish cause and effect with certainty. They did not measure inflammatory markers that might explain the mechanism, and they did not collect data on anxiety, depression, cancer stage, prior treatment, or sleep problems before surgery—all factors that could influence pain perception. Despite these constraints, the team concluded that vitamin D deficiency is associated with higher rates of moderate to severe postoperative pain and increased opioid use in patients undergoing mastectomy.
Based on their findings, the researchers suggest that breast cancer patients with vitamin D levels below 30 nmol/L might benefit from supplementation before surgery. Such preoperative intervention could potentially modulate pain after the operation, reducing both suffering and the need for opioid medications with their attendant risks. The next step would be a controlled trial to test whether supplementation actually prevents the pain and opioid consumption observed in this observational study.
Notable Quotes
Preoperative vitamin D supplementation in breast cancer patients with vitamin D levels below 30 nmol/L may have a role in modulating postoperative pain.— Study researchers, Regional Anesthesia & Pain Medicine
The Hearth Conversation Another angle on the story
Why would vitamin D specifically affect how someone feels pain after surgery?
The research suggests it's tied to inflammation and immune function. Vitamin D appears to help the body regulate its inflammatory response, which is a major driver of postoperative pain. When you're deficient, that regulatory system is weakened.
So this isn't just about the surgery itself—it's about the body's ability to manage what comes after?
Exactly. Everyone gets cut and sutured. But how much pain you feel depends partly on how your immune system and inflammatory pathways respond. Vitamin D seems to be one of the players in that response.
The study found they used a lot more tramadol. Is that because they were in more pain, or could there be something else?
The pain measurements showed they genuinely reported more moderate pain in the first 24 hours. So yes, they were hurting more. The tramadol use followed from that. But it's a concerning pattern because opioids have their own side effects—nausea, vomiting, the risk of dependency.
If this holds up, would supplementing everyone with vitamin D before surgery be the answer?
Not necessarily everyone. The researchers are specifically suggesting it for patients who test low—below 30 nmol/L. You'd want to know someone's vitamin D status beforehand. And this was one observational study at one hospital. You'd want a controlled trial to confirm that supplementation actually prevents the pain.
What's the biggest limitation here?
They couldn't measure the actual inflammatory markers or explore the mechanism. They also didn't account for things like anxiety or depression, which powerfully shape pain perception. So while the pattern is clear, we don't fully understand why it's happening.